Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.4 USD | +2.40% |
|
+21.17% | +36.60% |
07-01 | Raymond James Initiates AxoGen at Outperform With $13 Price Target | MT |
06-24 | Axogen, Inc. Announces Full Launch of Avive+ Soft Tissue Matrix | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.60% | 401M | |
+4.74% | 212B | |
+8.67% | 187B | |
+27.33% | 155B | |
+34.04% | 115B | |
+2.17% | 65.5B | |
+13.82% | 52.87B | |
-3.30% | 45.25B | |
-3.63% | 39.7B | |
+6.29% | 37.72B |
- Stock Market
- Equities
- AXGN Stock
- News AxoGen, Inc.
- AxoGen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2020